Chiral Technologies, Inc.

This application note demonstrates how the use of DCM in particular had a dramatic effect on the separation and afforded conditions that could be further adapted to a preparative scale application.

This application note shares new chiral separations for (±)-catechin and several Daicel immobilized chiral stationary phases. It also highlights elution order reversals.

This application note shares new chiral separations for the anti-viral, COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials.

See chiral separations for anti-viral COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials, on Daicel chiral and achiral columns.

Daicel’s CHIRALPAK® IJ gives access to an expanded range of solvents, which yields new separations not previously achievable on the coated CHIRALCEL® OJ.

This application note demonstrates the ability of Daicel’s CHIRALPAK® IA-3 to perform both chiral and achiral separations using SFC and hydrobenzoin as a test compound.

The launch of CHIRALPAK® IJ gives access to an expanded range of solvents, which yields new separation not previously achievable on the coated CHIRALCEL® OJ.

This application note demonstrates the ability of Daicel’s CHIRALPAK® IA-3 to perform both chiral and achiral separations using SFC and Hydrobenzoin as a test compound.

Daicel’s CHIRALPAK® IF proven to perform the difficult separations of cannabinoids Δ8-THC and Δ9-THC.

Supercritical fluid chromatography (SFC) is an evolutionary technology and a powerful tool for enantiomer separation when used in combination with chiral stationary phases (CSPs).